Epidemiology Articles

Gain free access to the latest articles on the NASH and NAFLD epidemic by a global expert community. ⌨

Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice

Authors: Ilagan-Ying Y, Ilagan-Ying B et al
Published in Current Gastroenterology Reports (2023)
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD) has emerged as a leading cause of chronic liver disease, affecting a staggering 30% of the global population.
Read MoreScreening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice

Cardiovascular Disease in MASLD Patients: Mitigating Risks

Authors: Mellemkjær A et al.
Published in European Journal of Internal Medicine (November 2023)
The term metabolic dysfunction-associated steatotic liver disease (MASLD) has recently been proposed as an alternative to non-alcoholic fatty liver disease (NAFLD)’s exclusionary nomenclature.
Read MoreCardiovascular Disease in MASLD Patients: Mitigating Risks

Global research on fatty liver disease: a review

Authors: Lazarus JV, Mark HE, Allen AM, et al.
Published in J Hepatol (September 2023)
In this study, a large, global, multidisciplinary panel discussed priorities within the field of fatty liver disease, including its burden, policies surrounding the issue and treatment options.
Read MoreGlobal research on fatty liver disease: a review

Managing Hepatocellular Carcinoma in NAFLD: a review

Authors: Cadar R, Lupascu Ursulescu C, Vasilescu AM, et al
Published in Life (Basel) (September 2023)
Currently, there are rising levels of non-alcoholic fatty liver disease (NAFLD). With this, comes a concurrent increase in hepatocellular carcinoma (HCC) cases.
Read MoreManaging Hepatocellular Carcinoma in NAFLD: a review

The new paradigm of cardiometabolic syndrome: a review

Authors: Khan AR, Salama AH, Aleem Z, et al.
Published in Cureus (September 2023)
Cardiometabolic syndrome (CMS) involves a complex interplay of many issues, involving obesity, metabolic dysregulation, cardiovascular disease, insulin resistance and more. This condition extends to clinical implications including non-alcoholic fatty liver disease (NAFLD) as well as cancer and sleep apnoea.
Read MoreThe new paradigm of cardiometabolic syndrome: a review

Discerning sex-related differences in NAFLD patients via metabolic profiling

Authors: Fotakis C, Kalafi IP, Amanitidou AI et al.
Published in Frontiers in Endocrinology (October 2023)
Research into personalised medicine for non-alcoholic fatty liver disease (NAFLD) underscores the importance of acknowledging NAFLD patients’ unique clinical phenotypes when developing targeted pharmacotherapies.
Read MoreDiscerning sex-related differences in NAFLD patients via metabolic profiling

Research Priorities in NAFLD: Ensuring Personalised and Multidisciplinary Patient Care

Authors: Iruzubieta P, Bataller R, Arias-Loste MT et al.
Published in Clinics in Liver Disease (May 2023)
Both non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), NAFLD’s inflammatory and progressive subtype, are the histologic manifestations of a heterogeneous disease intricately linked with metabolic disorders.
Read MoreResearch Priorities in NAFLD: Ensuring Personalised and Multidisciplinary Patient Care

The Long Road to NASH Therapeutics: Uncovering Valuable Insights

Authors: Tilg H, Byrne CD and Targher G
Published in The Lancet Gastroenterology and Hepatology (October 2023)
Recent research indicates that 30% of adults worldwide, 90% of those with obesity, and 70% with type 2 diabetes are affected by non-alcoholic fatty liver disease (NAFLD).
Read MoreThe Long Road to NASH Therapeutics: Uncovering Valuable Insights

Liver Stiffness and All-Cause Mortality in NAFLD Patients: Is There an Independent Link?

Authors: Ciardullo S, Muraca E, Zerbini F et al.
Published in Liver International (September 2023)
Liver-related events contribute to a small proportion of mortality within the collective cohort of patients with non-alcoholic fatty liver disease (NAFLD).
Read MoreLiver Stiffness and All-Cause Mortality in NAFLD Patients: Is There an Independent Link?

NAFLD and Pancreatic Steatosis: A Bidirectional Relationship?

Authors: Wongtrakul W, Untaaveesup S, Pausawadi N et al.
Published in European Journal of Gastroenterology & Hepatology (October 2023)
Recent research supports the existence of a potential link between non-alcoholic fatty liver disease (NAFLD) and fatty pancreas.
Read MoreNAFLD and Pancreatic Steatosis: A Bidirectional Relationship?

SUBSCRIBE & FOLLOW US

SUBSCRIBE TO OUR MONTHLY NEWSLETTER TO GET THE LATEST UPDATES